 | • レポートコード：QYR9ST07554 • 出版社/出版日：QYResearch / 2019年9月5日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥518,000 (USD3,500) | ▷ お問い合わせ |
| Enterprise License | ￥1,036,000 (USD7,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートは、ドルテグラビル・リルピビリン併用薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、自己生産API、APIのアウトソーシングに、用途別には、病院、診療所、薬物センター、その他にセグメント区分し、ドルテグラビル・リルピビリン併用薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・ドルテグラビル・リルピビリン併用薬の世界市場概要 ・ドルテグラビル・リルピビリン併用薬の製造コスト構成分析 ・ドルテグラビル・リルピビリン併用薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ドルテグラビル・リルピビリン併用薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ドルテグラビル・リルピビリン併用薬のセグメント分析（種類別） （自己生産API、APIのアウトソーシング） ・ドルテグラビル・リルピビリン併用薬のセグメント分析（用途別） （病院、診療所、薬物センター、その他） ・ドルテグラビル・リルピビリン併用薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績） （ViiV Healthcare、JNJ） ・ドルテグラビル・リルピビリン併用薬の市場規模予測（2019年～2025年） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・マーケティングチャネル・流通業者・顧客 ・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子） ... |
The global Dolutegravir/Rilpivirine Combination Drug market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Dolutegravir/Rilpivirine Combination Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Dolutegravir/Rilpivirine Combination Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Dolutegravir/Rilpivirine Combination Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Dolutegravir/Rilpivirine Combination Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
ViiV Healthcare
JNJ
…
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Self-production API
Outsourcing of API
Segment by Application
Hospital
Clinic
Drug Center
Other
Table of Contents
Executive Summary
1 Industry Overview of Dolutegravir/Rilpivirine Combination Drug
1.1 Definition of Dolutegravir/Rilpivirine Combination Drug
1.2 Dolutegravir/Rilpivirine Combination Drug Segment by Type
1.2.1 Global Dolutegravir/Rilpivirine Combination Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Self-production API
1.2.3 Outsourcing of API
1.3 Dolutegravir/Rilpivirine Combination Drug Segment by Applications
1.3.1 Global Dolutegravir/Rilpivirine Combination Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Drug Center
1.3.5 Other
1.4 Global Dolutegravir/Rilpivirine Combination Drug Overall Market
1.4.1 Global Dolutegravir/Rilpivirine Combination Drug Revenue (2014-2025)
1.4.2 Global Dolutegravir/Rilpivirine Combination Drug Production (2014-2025)
1.4.3 North America Dolutegravir/Rilpivirine Combination Drug Status and Prospect (2014-2025)
1.4.4 Europe Dolutegravir/Rilpivirine Combination Drug Status and Prospect (2014-2025)
1.4.5 China Dolutegravir/Rilpivirine Combination Drug Status and Prospect (2014-2025)
1.4.6 Japan Dolutegravir/Rilpivirine Combination Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Dolutegravir/Rilpivirine Combination Drug Status and Prospect (2014-2025)
1.4.8 India Dolutegravir/Rilpivirine Combination Drug Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Dolutegravir/Rilpivirine Combination Drug
2.3 Manufacturing Process Analysis of Dolutegravir/Rilpivirine Combination Drug
2.4 Industry Chain Structure of Dolutegravir/Rilpivirine Combination Drug
3 Development and Manufacturing Plants Analysis of Dolutegravir/Rilpivirine Combination Drug
3.1 Capacity and Commercial Production Date
3.2 Global Dolutegravir/Rilpivirine Combination Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Dolutegravir/Rilpivirine Combination Drug
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Dolutegravir/Rilpivirine Combination Drug Production and Capacity Analysis
4.2 Dolutegravir/Rilpivirine Combination Drug Revenue Analysis
4.3 Dolutegravir/Rilpivirine Combination Drug Price Analysis
4.4 Market Concentration Degree
5 Dolutegravir/Rilpivirine Combination Drug Regional Market Analysis
5.1 Dolutegravir/Rilpivirine Combination Drug Production by Regions
5.1.1 Global Dolutegravir/Rilpivirine Combination Drug Production by Regions
5.1.2 Global Dolutegravir/Rilpivirine Combination Drug Revenue by Regions
5.2 Dolutegravir/Rilpivirine Combination Drug Consumption by Regions
5.3 North America Dolutegravir/Rilpivirine Combination Drug Market Analysis
5.3.1 North America Dolutegravir/Rilpivirine Combination Drug Production
5.3.2 North America Dolutegravir/Rilpivirine Combination Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Dolutegravir/Rilpivirine Combination Drug Import and Export
5.4 Europe Dolutegravir/Rilpivirine Combination Drug Market Analysis
5.4.1 Europe Dolutegravir/Rilpivirine Combination Drug Production
5.4.2 Europe Dolutegravir/Rilpivirine Combination Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Dolutegravir/Rilpivirine Combination Drug Import and Export
5.5 China Dolutegravir/Rilpivirine Combination Drug Market Analysis
5.5.1 China Dolutegravir/Rilpivirine Combination Drug Production
5.5.2 China Dolutegravir/Rilpivirine Combination Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Dolutegravir/Rilpivirine Combination Drug Import and Export
5.6 Japan Dolutegravir/Rilpivirine Combination Drug Market Analysis
5.6.1 Japan Dolutegravir/Rilpivirine Combination Drug Production
5.6.2 Japan Dolutegravir/Rilpivirine Combination Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Dolutegravir/Rilpivirine Combination Drug Import and Export
5.7 Southeast Asia Dolutegravir/Rilpivirine Combination Drug Market Analysis
5.7.1 Southeast Asia Dolutegravir/Rilpivirine Combination Drug Production
5.7.2 Southeast Asia Dolutegravir/Rilpivirine Combination Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Dolutegravir/Rilpivirine Combination Drug Import and Export
5.8 India Dolutegravir/Rilpivirine Combination Drug Market Analysis
5.8.1 India Dolutegravir/Rilpivirine Combination Drug Production
5.8.2 India Dolutegravir/Rilpivirine Combination Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Dolutegravir/Rilpivirine Combination Drug Import and Export
6 Dolutegravir/Rilpivirine Combination Drug Segment Market Analysis (by Type)
6.1 Global Dolutegravir/Rilpivirine Combination Drug Production by Type
6.2 Global Dolutegravir/Rilpivirine Combination Drug Revenue by Type
6.3 Dolutegravir/Rilpivirine Combination Drug Price by Type
7 Dolutegravir/Rilpivirine Combination Drug Segment Market Analysis (by Application)
7.1 Global Dolutegravir/Rilpivirine Combination Drug Consumption by Application
7.2 Global Dolutegravir/Rilpivirine Combination Drug Consumption Market Share by Application (2014-2019)
8 Dolutegravir/Rilpivirine Combination Drug Major Manufacturers Analysis
8.1 ViiV Healthcare
8.1.1 ViiV Healthcare Dolutegravir/Rilpivirine Combination Drug Production Sites and Area Served
8.1.2 ViiV Healthcare Product Introduction, Application and Specification
8.1.3 ViiV Healthcare Dolutegravir/Rilpivirine Combination Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 JNJ
8.2.1 JNJ Dolutegravir/Rilpivirine Combination Drug Production Sites and Area Served
8.2.2 JNJ Product Introduction, Application and Specification
8.2.3 JNJ Dolutegravir/Rilpivirine Combination Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
9 Development Trend of Analysis of Dolutegravir/Rilpivirine Combination Drug Market
9.1 Global Dolutegravir/Rilpivirine Combination Drug Market Trend Analysis
9.1.1 Global Dolutegravir/Rilpivirine Combination Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Dolutegravir/Rilpivirine Combination Drug Regional Market Trend
9.2.1 North America Dolutegravir/Rilpivirine Combination Drug Forecast 2019-2025
9.2.2 Europe Dolutegravir/Rilpivirine Combination Drug Forecast 2019-2025
9.2.3 China Dolutegravir/Rilpivirine Combination Drug Forecast 2019-2025
9.2.4 Japan Dolutegravir/Rilpivirine Combination Drug Forecast 2019-2025
9.2.5 Southeast Asia Dolutegravir/Rilpivirine Combination Drug Forecast 2019-2025
9.2.6 India Dolutegravir/Rilpivirine Combination Drug Forecast 2019-2025
9.3 Dolutegravir/Rilpivirine Combination Drug Market Trend (Product Type)
9.4 Dolutegravir/Rilpivirine Combination Drug Market Trend (Application)
10 Marketing Channel, Distributors and Customers
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Dolutegravir/Rilpivirine Combination Drug Distributors List
10.3 Dolutegravir/Rilpivirine Combination Drug Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Figure Picture of Dolutegravir/Rilpivirine Combination Drug
Table Global Dolutegravir/Rilpivirine Combination Drug Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Dolutegravir/Rilpivirine Combination Drug Production Market Share by Types in 2018
Figure Self-production API Product Picture
Figure Outsourcing of API Product Picture
Table Global Dolutegravir/Rilpivirine Combination Drug Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Dolutegravir/Rilpivirine Combination Drug Consumption Market Share by Applications in 2018
Figure Hospital
Figure Clinic
Figure Drug Center
Figure Other
Figure Global Dolutegravir/Rilpivirine Combination Drug Revenue (Million USD) (2014-2025)
Figure Global Dolutegravir/Rilpivirine Combination Drug Production (K Pcs) (2014-2025)
Figure North America Dolutegravir/Rilpivirine Combination Drug Market Size (Million USD) (2014-2025)
Figure Europe Dolutegravir/Rilpivirine Combination Drug Market Size (Million USD) (2014-2025)
Figure China Dolutegravir/Rilpivirine Combination Drug Market Size (Million USD) (2014-2025)
Figure Japan Dolutegravir/Rilpivirine Combination Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Dolutegravir/Rilpivirine Combination Drug Market Size (Million USD) (2014-2025)
Figure India Dolutegravir/Rilpivirine Combination Drug Market Size (Million USD) (2014-2025)
Table Dolutegravir/Rilpivirine Combination Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Dolutegravir/Rilpivirine Combination Drug in 2018
Figure Manufacturing Process Analysis of Dolutegravir/Rilpivirine Combination Drug
Figure Industry Chain Structure of Dolutegravir/Rilpivirine Combination Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Dolutegravir/Rilpivirine Combination Drug Manufacturing Plants Distribution
Table Dolutegravir/Rilpivirine Combination Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Dolutegravir/Rilpivirine Combination Drug Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Dolutegravir/Rilpivirine Combination Drug Production (K Pcs) of Major Manufacturers (2014-2019)
Table Dolutegravir/Rilpivirine Combination Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Dolutegravir/Rilpivirine Combination Drug Production Share by Manufacturers in 2018
Table Dolutegravir/Rilpivirine Combination Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Dolutegravir/Rilpivirine Combination Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Dolutegravir/Rilpivirine Combination Drug Revenue Share by Manufacturers in 2018
Table Dolutegravir/Rilpivirine Combination Drug Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Dolutegravir/Rilpivirine Combination Drug Production by Regions 2014-2019 (K Pcs)
Table Global Dolutegravir/Rilpivirine Combination Drug Production Market Share by Regions 2014-2019
Figure Global Dolutegravir/Rilpivirine Combination Drug Production Market Share by Regions in 2018
Table Global Dolutegravir/Rilpivirine Combination Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Dolutegravir/Rilpivirine Combination Drug Revenue Market Share by Regions 2014-2019
Figure Global Dolutegravir/Rilpivirine Combination Drug Revenue Market Share by Regions in 2018
Table Global Dolutegravir/Rilpivirine Combination Drug Consumption by Regions 2014-2019 (K Pcs)
Table Global Dolutegravir/Rilpivirine Combination Drug Consumption Market Share by Regions 2014-2019
Figure North America Dolutegravir/Rilpivirine Combination Drug Production Growth Rate 2014-2019 (K Pcs)
Figure North America Dolutegravir/Rilpivirine Combination Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Dolutegravir/Rilpivirine Combination Drug Production, Consumption Import and Export (K Pcs)
Figure Europe Dolutegravir/Rilpivirine Combination Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Dolutegravir/Rilpivirine Combination Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Dolutegravir/Rilpivirine Combination Drug Production, Consumption Import and Export (K Pcs)
Figure China Dolutegravir/Rilpivirine Combination Drug Production Growth Rate 2014-2019 (K Pcs)
Figure China Dolutegravir/Rilpivirine Combination Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Dolutegravir/Rilpivirine Combination Drug Production, Consumption Import and Export (K Pcs)
Figure Japan Dolutegravir/Rilpivirine Combination Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Dolutegravir/Rilpivirine Combination Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Dolutegravir/Rilpivirine Combination Drug Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Dolutegravir/Rilpivirine Combination Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Dolutegravir/Rilpivirine Combination Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Dolutegravir/Rilpivirine Combination Drug Production, Consumption Import and Export (K Pcs)
Figure India Dolutegravir/Rilpivirine Combination Drug Production Growth Rate 2014-2019 (K Pcs)
Figure India Dolutegravir/Rilpivirine Combination Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Dolutegravir/Rilpivirine Combination Drug Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Dolutegravir/Rilpivirine Combination Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Dolutegravir/Rilpivirine Combination Drug Market Share by Application (2014-2019)
Table ViiV Healthcare Dolutegravir/Rilpivirine Combination Drug Production Sites and Area Served
Table ViiV Healthcare Dolutegravir/Rilpivirine Combination Drug Product Introduction, Application and Specification
Table ViiV Healthcare Dolutegravir/Rilpivirine Combination Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table ViiV Healthcare Dolutegravir/Rilpivirine Combination Drug Production Growth Rate (2014-2019)
Table ViiV Healthcare Dolutegravir/Rilpivirine Combination Drug Production Market Share (2014-2019)
Figure ViiV Healthcare Dolutegravir/Rilpivirine Combination Drug Revenue Market Share (2014-2019)
Table ViiV Healthcare Dolutegravir/Rilpivirine Combination Drug Main Business and Markets Served
Table JNJ Dolutegravir/Rilpivirine Combination Drug Production Sites and Area Served
Table JNJ Dolutegravir/Rilpivirine Combination Drug Product Introduction, Application and Specification
Table JNJ Dolutegravir/Rilpivirine Combination Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table JNJ Dolutegravir/Rilpivirine Combination Drug Production Growth Rate (2014-2019)
Table JNJ Dolutegravir/Rilpivirine Combination Drug Production Market Share (2014-2019)
Figure JNJ Dolutegravir/Rilpivirine Combination Drug Revenue Market Share (2014-2019)
Table JNJ Dolutegravir/Rilpivirine Combination Drug Main Business and Markets Served
Figure Global Dolutegravir/Rilpivirine Combination Drug Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Dolutegravir/Rilpivirine Combination Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Dolutegravir/Rilpivirine Combination Drug Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Dolutegravir/Rilpivirine Combination Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Dolutegravir/Rilpivirine Combination Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Dolutegravir/Rilpivirine Combination Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Dolutegravir/Rilpivirine Combination Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Dolutegravir/Rilpivirine Combination Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Dolutegravir/Rilpivirine Combination Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Dolutegravir/Rilpivirine Combination Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Dolutegravir/Rilpivirine Combination Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Dolutegravir/Rilpivirine Combination Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Dolutegravir/Rilpivirine Combination Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Dolutegravir/Rilpivirine Combination Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Dolutegravir/Rilpivirine Combination Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Dolutegravir/Rilpivirine Combination Drug by Type (2019-2025)
Table Global Consumption (K Pcs) of Dolutegravir/Rilpivirine Combination Drug by Application (2019-2025)
Table Dolutegravir/Rilpivirine Combination Drug Distributors List
Table Dolutegravir/Rilpivirine Combination Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界のエムトリシタビン・リルピビリン・テノフォビルアラフェナミド市場：専門的調査 The global Emtricitabine/Rilpivirine/Tenofovir Alafenamide market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Emtricitabine/Rilpivirine/Tenofovir Alafenamide volume and value at global level,…- 世界のリルピビリン市場：専門的調査 The global Rilpivirine market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Rilpivirine volume and value at global level, regional level and company level. From a global perspective, this repor…
- 世界のドルテグラビル市場：専門的調査 The global Dolutegravir market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Dolutegravir volume and value at global level, regional level and company level. From a global perspective, this rep…
- 世界のドルテグラビル市場：専門的調査 The global Dolutegravir market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Dolutegravir volume and value at global level, regional level and company level. From a global perspective, this rep…
- 世界のテノフォビル/ラミブジン/アタザナビル/リトナビル併用薬市場：専門的調査 The global Tenofovir/Lamivudine/Atazanavir/Ritonavir Combination Drug market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Tenofovir/Lamivudine/Atazanavir/Ritonavir Combination Drug volume and …